(S)-2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid,
(S)-2-ethoxy-3-(4-(2-(4-methylsulphonyloxyphenyl)ethoxy)phenyl)propanoic acid,
2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid,
AZ 242,
tesaglitazar,
Tesaglitazar,
251565-85-2,
Galida,
(S)-2-Ethoxy-3-(4-(4-((methylsulfonyl)oxy)phenethoxy)phenyl)propanoic acid,
AZ 242,
AR-H039242XX,
AZ-242,
(S)-2-Ethoxy-3-{4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl}propionic acid,
UNII-6734037O3L,
(S)-2-Ethoxy-3-{4-[2-(4-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionic acid,
(2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid,
BR-44608,
6734037O3L,
(S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoic acid,
(2S)-2-ETHOXY-3-[4-(2-{4-[(METHYLSULFONYL)OXY]PHENYL}ETHOXY)PHENYL]PROPANOIC ACID,
(2S)-2-ethoxy-3-(4-{2-[4-(methanesulfonyloxy)phenyl]ethoxy}phenyl)propanoic acid,
Benzenepropanoic acid, alpha-ethoxy-4-(2-(4-((methylsulfonyl)oxy)phenyl)ethoxy)-, (alphaS)-,
Tesaglitazar [USAN:INN],
Tesaglitizar,
(2S)-2-Ethoxy-3-(4-(2-(4-((methylsulfonyl)oxy)phenyl)ethoxy)phenyl)propanoic acid,
(s)-2-ethoxy-3-(4-[2-(4-methanesulfonyloxy-phenyl)-ethoxy]-phenyl)-propionic acid,
(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl]propanoic acid,
(S)-2-ETHOXY-3-[4-[2-(4-METHANESULFONYLOXY-PHENYL)-ETHOXY]-PHENYL]-PROPIONIC ACID,
(s)-2-ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propionic acid,
(S)-2-Ethoxy-3-[4-[4-[(methylsulfonyl)oxy]phenethoxy]phenyl]propanoic Acid,
NCGC00182082-02,
Benzenepropanoic acid, alpha-ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]-, (alphaS)-,
(s)-2-ethoxy-3-(4-(2-(4-methylsulphonyloxyphenyl)ethoxy)phenyl)propanoic acid,
1i7g,
1i7i,
AC1L4LKJ,
AC1Q6XZG,
SCHEMBL16594,
MLS004774044,
CHEMBL282686,
Tesaglitazar (JAN/USAN/INN),
BDBM28798,
C20H24O7S,
CTK1A2643,
Tesaglitazar, >=98% (HPLC),
CXGTZJYQWSUFET-IBGZPJMESA-N,
ACT04873,
BCP23582,
ZINC1550769,
ANW-48037,
MFCD07784004,
AKOS015920483,
AC-6748,
AN-5861,
API0000853,
AS06690,
DB07399,
AJ-26892,
AK-44608,
AS-35360,
BC676873,
SMR003500714,
AB0023714,
AX8032871,
RT-015976,
ST2414605,
B7553,
FT-0674871,
W4836,
D01274,
S-7651,
J-015842,
(S)-2-ethoxy-3-(4-(4-(methylsulfonyloxy)phenethoxy)phenyl)propanoic acid,
(2S)-2-Ethoxy-3-(4-(2-(4-((methylsulfonyl)oxy)phenyl)ethoxy)phenyl)propionic acid,
(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy)phenyl]propanoic acid,
(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}-ethoxy)phenyl]propanoic acid,
(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy) phenyl]propanoic acid,
(S)-2-Ethoxy-3-[4-[[4-(methylsulphonyloxy)phenethyl]oxy]phenyl]propanoic acid,
benzenepropanoic acid, a-ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]-, (as)-,
(S)-2-ETHOXY-3-[4-[2-(4-METHANESULFONYLOXY-PHENYL)-ETHOXY]-PHENYL]-PROPIONIC ACID TESAGLITAZAR (S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phe,
Tesaglitazar [INN],
D0H1NL,
KST-1A3565,
AR-1A7859,
C20-H24-O7-S,
CID208901,
T3497,
C476728,
C501413,
2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid,
29822-06-8,
AZ2,
(alpha S)-alpha-Ethoxy-4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]benzenepropanoic acid,
(S)-2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid,
(S)-2-ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]-propanoic acid,